Exclusive

Publication

Byline

Agilent expands Altura portfolio with inert size exclusion and PLRP-S columns for biotherapeutic analysis

Singapore, July 9 -- Agilent Technologies Inc. has announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLR... Read More


Aegros builds Australia's second human plasma fractionation facility

Singapore, July 9 -- Australian biotech Aegros has completed Australia's second human plasma fractionation facility, joining CSL's long-established footprint. The 4000 sq mt Macquarie Park facility wi... Read More


Malaysia, Thailand set to start global clinical trial for Serum Institute of India's dengue treatment

Singapore, July 9 -- The Serum Institute of India (SII) and the non-profit medical research organisation Drugs for Neglected Diseases initiative (DNDi) have signed a licensing agreement covering clini... Read More


Singapore Medical Foundation AI Model launches for effective public healthcare

Singapore, July 9 -- Most AI foundation models used in healthcare today are trained on data from Western populations, which can limit the accuracy and relevance in Singapore's clinical settings. As a... Read More


RoosterBio, Qkine partner to support stem cell and exosome therapy development

Singapore, July 8 -- RoosterBio and Qkine have entered a distribution agreement to provide U.S. customers with a single-source platform for cells, bioprocess media and recombinant growth factors. The... Read More


Catalent, Nanoscope expand partnership for optogenetic gene therapy supply

Singapore, July 8 -- Catalent and Nanoscope Therapeutics have expanded their partnership to support late-phase clinical development and commercial supply of MCO-010, Nanoscope's lead optogenetic gene ... Read More


FibroBiologics completes third cGMP batch for fibroblast therapy trial

Singapore, July 8 -- FibroBiologics has completed manufacturing of the third batch of CYWC628 drug product for its ongoing Phase 1/2 clinical trial in patients with diabetic foot ulcers. The batch wa... Read More


Bristol Myers Squibb names Singapore as new Pan Asia Hub

Singapore, July 8 -- Bristol Myers Squibb (BMS), a global biopharmaceutical leader, recently celebrated its 60th anniversary in Singapore by recognising it as a new Pan Asia Cluster (PAC) hub for the ... Read More


Australia's breakthrough in search for Motor Neurone Disease treatment

Singapore, July 8 -- Australia-based University of Queensland (UQ) researchers have developed a drug that activates a hard-to-target immune receptor - a breakthrough which could lead to new treatments... Read More


Japan's Tanabe sells Pharma Factory to Towa Pharmaceutical

Singapore, July 8 -- Japan-based Tanabe Pharma has decided to transfer the domestic manufacturing and marketing approvals, manufacturing and marketing rights, and related assets for 17 products across... Read More